Leena Kankaanranta
Papers
1
Total Citations
18
H-Index
1
About
Leena Kankaanranta is a leading figure in the advancement of boron neutron capture therapy (BNCT), a targeted form of radiation oncology. Her key research areas center on the clinical translation of BNCT, particularly its evolution from nuclear reactor-based to proton accelerator-based delivery systems. Dr. Kankaanranta’s major contribution is her comprehensive review of the Finnish BNCT experience, which analyzed outcomes for 249 patients treated at Helsinki University Hospital between 1999 and 2012. This pivotal work, cited 18 times, documented the use of reactor-derived neutrons and the boron carrier l-BPA-F, providing critical evidence for the therapy’s safety and efficacy. Her research has been instrumental in demonstrating BNCT’s clinical viability, especially for head and neck cancers and brain tumors, and has helped pave the way for next-generation accelerator-based BNCT facilities. By bridging the gap between experimental nuclear medicine and practical patient care, Kankaanranta has established herself as a key architect in the global effort to make this precision therapy more widely accessible.
Research Focus
Key Achievements
Top Papers
- 1